Research Progress on Influenza A Virus and Nervous System Disease of Human and Experimental Animals

doi:10.12300/j.issn.1674-5817.2022.142

Abstract

Abstract:

Influenza is a highly contagious disease that mainly affects the respiratory system and often leads to lung complications. Also it can cause a variety of very rare and serious neurological complications, including Guillain-Barre syndrome, transverse myelitis, meningoencephalitis and others. In recent years, neurological complications caused by influenza A virus have been reported in many countries and regions, and gradually attracted international attention. However, the pathogenesis of this complication remains unclear, and there are few related cases and animal experimental studies,and no specific treatment. Therefore, the authors summarized the study of neurological complications caused by influenza A virus in human and laboratory animals, in order to have a comprehensive understanding of the neurological diseases caused by influenza A virus.

Key words: Influenza A virus, Neurological complications, Animal experiment

CLC Number:

R-332

Xiangrong DING, Shurui HUO, Jiejie DAI. Research Progress on Influenza A Virus and Nervous System Disease of Human and Experimental Animals[J]. Laboratory Animal and Comparative Medicine, 2023, 43(2): 180-185.

References 39

1	ALAJANGI H K, KAUR M, SHARMA A, et al. Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders[J]. Mol Brain, 2022, 15(1):49. DOI: 10.1186/s13041-022-00937-4 .
2	AMPIE L, MCGAVERN D B. Immunological defense of CNS barriers against infections[J]. Immunity, 2022, 55(5): 781-799. DOI: 10.1016/j.immuni.2022.04.012 .
3	ROMERO J R, NEWLAND J G. Viral meningitis and encephalitis: traditional and emerging viral agents[J]. Semin Pediatr Infect Dis, 2003, 14(2):72-82. DOI: 10.1053/spid.2003. 127223 .
4	兰旭, 邓春青. 甲型流感病毒血凝素研究进展[J]. 中国人兽共患病学报, 2021, 37(6):563-570. DOI: 10.3969/j.issn.1002-2694. 2021.00.055 .
	LAN X, DENG C Q. Research progress in influenza A virus hemagglutinin[J]. Chin J Zoonoses, 2021, 37(6):563-570. DOI: 10.3969/j.issn.1002-2694.2021.00.055 .
5	CHEN Q L, LI P Q, LI S Y, et al. Brain complications with influenza infection in children[J]. J Behav Brain Sci, 2020, 10(3):129-152. DOI: 10.4236/jbbs.2020.103008 .
6	HOSSEINI S, MICHAELSEN-PREUSSE K, SCHUGHART K, et al. Long-term consequence of non-neurotropic H3N2 influenza A virus infection for the progression of alzheimer's disease symptoms[J]. Front Cell Neurosci, 2021, 15:643650. DOI: 10.3389/fncel.2021.643650 .
7	HAN J Y, HAN S B. Seizures related to influenza in pediatric patients: a comparison with seizures associated with other respiratory viral infections[J]. J Clin Med, 2021, 10(14):3088. DOI: 10.3390/jcm10143088 .
8	LEUNG YU M K, LEUNG C P P, WONG W H S, et al. Clinical spectrum and burden of influenza-associated neurological complications in hospitalised paediatric patients[J]. Front Pediatr, 2021, 9:752816. DOI: 10.3389/fped.2021.752816 .
9	SAWIRES R, KULDORFF M, FAHEY M, et al. Snotwatch: an ecological analysis of the relationship between febrile seizures and respiratory virus activity[J]. BMC Pediatr, 2022, 22(1):359. DOI: 10.1186/s12887-022-03222-4 .
10	KWONG K L, LAM S Y, QUE T L, et al. Influenza A and febrile seizures in childhood[J]. Pediatr Neurol, 2006, 35(6):395-399. DOI: 10.1016/j.pediatrneurol.2006.07.005 .
11	HAN J Y, HAN S B. Febrile seizures and respiratory viruses determined by multiplex polymerase chain reaction test and clinical diagnosis[J]. Children (Basel), 2020, 7(11):234. DOI: 10.3390/children7110234 .
12	EKSTRAND J J. Neurologic complications of influenza[J]. Semin Pediatr Neurol, 2012, 19(3):96-100. DOI: 10.1016/j.spen. 2012.02.004 .
13	SUGAYA N. Influenza-associated encephalopathy in Japan[J]. Semin Pediatr Infect Dis, 2002, 13(2):79-84. DOI: 10.1053/spid.2002.122993 .
14	雷雨璇, 舒跃龙, 房师松. 流感相关中枢神经系统并发症研究进展[J]. 病毒学报, 2022, 38(1):196-204. DOI: 10.13242/j.cnki.bingduxuebao.004088 .
	LEI Y X, SHU Y L, FANG S S. Research progress on influenza-related complications of the central nervous system[J]. Chin J Virol, 2022, 38(1):196-204. DOI: 10.13242/j.cnki.bingduxuebao.004088 .
15	KHORRAMDELAZAD H, KAZEMI M H, NAJAFI A, et al. Immunopathological similarities between COVID-19 and influenza: investigating the consequences of Co-infection[J]. Microb Pathog, 2021, 152: 104554. DOI: 10.1016/j.micpath. 2020.104554 .
16	MASTROLIA M V, RUBINO C, RESTI M, et al. Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in a tertiary pediatric hospital in Italy, 2017-2019[J]. BMC Infect Dis, 2019, 19(1):1012. DOI: 10.1186/s12879-019-4636-5 .
17	GU Y N, ZUO X, ZHANG S Y, et al. The mechanism behind influenza virus cytokine storm[J]. Viruses, 2021, 13(7):1362. DOI: 10.3390/v13071362 .
18	RADZIŠAUSKIENĖ D, VITKAUSKAITĖ M, ŽVINYTĖ K, et al. Neurological complications of pandemic A(H1N1)2009pdm, postpandemic A(H1N1)v, and seasonal influenza A[J]. Brain Behav, 2021, 11(1):e01916. DOI: 10.1002/brb3.1916 .
19	NG Y P, YIP T F, PEIRIS J S M, et al. Avian influenza A H7N9 virus infects human astrocytes and neuronal cells and induces inflammatory immune responses[J]. J Neurovirol, 2018, 24(6):752-760. DOI: 10.1007/s13365-018-0659-8 .
20	WANG G F, ZHANG J, LI W Z, et al. Apoptosis and proinflammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses[J]. Cell Mol Immunol, 2008, 5(2):113-120. DOI: 10.1038/cmi.2008.14 .
21	SHORT K R, VEERIS R, LEIJTEN L M, et al. Proinflammatory cytokine responses in extra-respiratory tissues during severe influenza[J]. J Infect Dis, 2017, 216(7):829-833. DOI: 10.1093/infdis/jix281 .
22	WANG S Y, LE T Q, KURIHARA N, et al. Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza[J]. J Infect Dis, 2010, 202(7):991-1001. DOI: 10.1086/656044 .
23	BOHMWALD K, ANDRADE C A, KALERGIS A M. Contribution of pro-inflammatory molecules induced by respiratory virus infections to neurological disorders[J]. Pharmaceuticals (Basel), 2021, 14(4):340. DOI: 10.3390/ph14040340 .
24	LI R F, YUAN B, XIA X S, et al. Tree shrew as a new animal model to study the pathogenesis of avian influenza (H9N2) virus infection[J]. Emerg Microbes Infect, 2018, 7(1):166. DOI: 10.1038/s41426-018-0167-1 .
25	KAYESH M E H, SANADA T, KOHARA M, et al. Tree shrew as an emerging small animal model for human viral infection: a recent overview[J]. Viruses, 2021, 13(8):1641. DOI: 10.3390/v13081641 .
26	周风梅, 李润峰, 袁兵, 等. 树鼩应用于病毒感染性疾病动物模型的研究进展[J]. 中国比较医学杂志, 2018, 28(6):115-120. DOI: 10.3969/j.issn.1671-7856.2018.06.021 .
	ZHOU F M, LI R F, YUAN B, et al. Research advances of application of tree shrew as an animal model of viral infectious diseases[J]. Chin J Comp Med, 2018, 28(6):115-120. DOI: 10.3969/j.issn.1671-7856.2018.06.021 .
27	MORISHIMA T, TOGASHI T, YOKOTA S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan[J]. Clin Infect Dis, 2002, 35(5):512-517. DOI: 10.1086/341407 .
28	姚敏, 汪晓莺, 董志珍, 等. 甲型流感病毒感染对鼠脑组织线粒体脂代谢功能的影响[J]. 南通大学学报(医学版), 2012, 32(1):18-21. DOI: 10.3969/j.issn.1674-7887.2012.01.006 .
	YAO M, WANG X Y, DONG Z Z, et al. Effect of influenza A virus infection on function of fat metabolism in mouse brain mitochondria[J]. J Nantong Univ Med Sci, 2012, 32(1):18-21. DOI: 10.3969/j.issn.1674-7887.2012.01.006 .
29	YAMADA M, BINGHAM J, PAYNE J, et al. Multiple routes of invasion of wild-type Clade 1 highly pathogenic avian influenza H5N1 virus into the central nervous system (CNS) after intranasal exposure in ferrets[J]. Acta Neuropathol, 2012, 124(4):505-516. DOI: 10.1007/s00401-012-1010-8 .
30	JANG H, BOLTZ D, STURM-RAMIREZ K, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration[J]. Proc Natl Acad Sci USA, 2009, 106(33):14063-14068. DOI: 10.1073/pnas.0900096106 .
31	PARK C H, ISHINAKA M, TAKADA A, et al. The invasion routes of neurovirulent A/Hong Kong/483/97 (H5N1) influenza virus into the central nervous system after respiratory infection in mice[J]. Arch Virol, 2002, 147(7):1425-1436. DOI: 10.1007/s00705-001-0750-x .
32	DE WIT E, SIEGERS J Y, CRONIN J M, et al. 1918 H1N1 influenza virus replicates and induces proinflammatory cytokine responses in extrarespiratory tissues of ferrets[J]. J Infect Dis, 2018, 217(8): 1237-1246. DOI: 10.1093/infdis/jiy003 .
33	DOU Y C, LI Y Q. Influenza A H3N2-associated meningoencephalitis in an older adult with viral RNA in cerebrospinal fluid: case report[J]. Front Neurol, 2022, 13:874078. DOI: 10.3389/fneur.2022.874078 .
34	MAK G C K, KWAN M Y W, MOK C K P, et al. Influenza A(H5N1) virus infection in a child with encephalitis complicated by obstructive hydrocephalus[J]. Clin Infect Dis, 2018, 66(1):136-139. DOI: 10.1093/cid/cix707 .
35	FROGGATT H M, HEATON N S. Nonrespiratory sites of influenza-associated disease: mechanisms and experimental systems for continued study[J]. FEBS J, 2022, 289(14):4038-4060. DOI: 10.1111/febs.16363 .
36	SMEYNE R J, NOYCE A J, BYRNE M, et al. Infection and risk of parkinson's disease[J]. J Parkinsons Dis, 2021, 11(1):31-43. DOI: 10.3233/JPD-202279 .
37	JANG H, BOLTZ D, MCCLAREN J, et al. Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice[J]. J Neurosci, 2012, 32(5):1545-1559. DOI: 10.1523/JNEUROSCI.5123-11.2012 .
38	MARREIROS R, MÜLLER-SCHIFFMANN A, TROSSBACH S V, et al. Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation[J]. Proc Natl Acad Sci USA, 2020, 117(12):6741-6751. DOI: 10.1073/pnas.1906466117 .
39	HOSSEINI S, WILK E, MICHAELSEN-PREUSSE K, et al. Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function[J]. J Neurosci, 2018, 38(12):3060-3080. DOI: 10.1523/JNEUROSCI.1740-17.2018 .

[1]	Zhengwen MA, Xiaying LI, Xiaoyu LIU, Yao LI, Jian WANG, Jin LU, Guoyuan CHEN, Xiao LU, Yu BAI, Xuancheng LU, Yonggang LIU, Wanyong PANG, Yufeng TAO. Interpretation and Elaboration for the ARRIVE Guidelines 2.0—Animal Research: Reporting In Vivo Experiments (V) [J]. Laboratory Animal and Comparative Medicine, 2024, 44(1): 105-114.
[2]	Jinhuan MIAO, Xia XU, Lu ZHOU, Haiyan CHENG, Yan HE. Visual Analysis of Animal Experiments on Traditional Chinese Medicine (TCM) Nursing Technology Based on VOSviewer [J]. Laboratory Animal and Comparative Medicine, 2023, 43(6): 626-635.
[3]	Xiaying LI, Yonglu TIAN, Xiaoyu LIU, Xuancheng LU, Guoyuan CHEN, Xiao LU, Yu BAI, Jing GAO, Yao LI, Yusheng WEI, Wanyong PANG, Yufeng TAO. Explanation and Elaboration for the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅳ) [J]. Laboratory Animal and Comparative Medicine, 2023, 43(6): 659-668.
[4]	Shuo WANG, Yunhui LÜ, Xiaokang WANG, Zhenhao ZHANG, Yongchun CUI. Construction and Verification of Quality Evaluation Indicator System for Extracorporeal Membrane Oxygenation Animal Experimental Platform [J]. Laboratory Animal and Comparative Medicine, 2023, 43(6): 604-611.
[5]	Xiaoyu LIU, Xuancheng LU, Xiaomeng SHI, Yuzhou ZHANG, Chao LÜ, Guoyuan CHEN, Xiao LU, Yu BAI, Jing GAO, Yao LI, Yonggang LIU, Yufeng TAO, Wanyong PANG. Explanation and Elaboration for the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅲ) [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 446-456.
[6]	Guoyuan CHEN, Xiao LU, Yu BAI, Lingzhi YU, Ying QIAO, Jian WANG, Jin LU, Xiaoyu LIU, Xuancheng LU, Jing GAO, Yao LI, Wanyong PANG. Explanation and Elaboration of the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅱ) [J]. Laboratory Animal and Comparative Medicine, 2023, 43(3): 323-331.
[7]	Jian WANG, Jin LU, Zhengwen MA, Guoyuan CHEN, Xiao LU, Yu BAI, Xiaoyu LIU, Xuancheng LU, Jing GAO, Yao LI, Wanyong Pang. Explanation and Elaboration for the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅰ) [J]. Laboratory Animal and Comparative Medicine, 2023, 43(2): 213-224.
[8]	Junyan ZHANG, Xiaoyu LIU, Yao LI, Guoyuan CHEN, Xiao LU, Yu BAI, Xuancheng LU, Wanyong PANG, Baojin WU. Introduction to the International Guide for Animal Research Reporting ARRIVE 2.0, and Its Implementation Plan in the Journal [J]. Laboratory Animal and Comparative Medicine, 2023, 43(1): 86-94.
[9]	Xiangmei LIU, Zhongchun MA, Hongkun FU, Feng GAO, Yufeng TAO. Discussion on Expression of Laboratory Accreditation Scope in the Field of Toxicology Testing [J]. Laboratory Animal and Comparative Medicine, 2022, 42(6): 526-530.
[10]	Xiaokang WANG, Ruojin ZHAO, Yunhui LÜ, Guangxin YUE, Shangyu LIU, Ting HE, Peng PENG, Liang MENG, Jubo LI, Baojie ZHANG, Chen SHEN, Yongchun CUI, Xin WANG. A Novel Model for in-vivo Training of Postgraduates on Cardiac Electrical Conduction System Mapping Skills [J]. Laboratory Animal and Comparative Medicine, 2022, 42(5): 466-471.
[11]	Yufei LENG, Wenjing LU, Fengwei WANG. Thinking of Teaching Reform in the Animal Experiment of Operative Surgery in Medical School [J]. Laboratory Animal and Comparative Medicine, 2022, 42(5): 472-476.
[12]	YU Yixiang, CAO Shanshan, FENG Yi, LI Jiarui, WANG Rong. Improvement and Effect Evaluation on Method of Tracheal Instillation in Rats [J]. Laboratory Animal and Comparative Medicine, 2021, 41(6): 543-546.
[13]	CHEN Xiaojuan, LI Wei, WANG Lie. Exploration on Informatization of Laboratory Animal Management Process in Colleges and Universities: The Case of Zhejiang University [J]. Laboratory Animal and Comparative Medicine, 2021, 41(6): 554-558.
[14]	ZHOU Bin, ZHAO Yong, WANG Yabing, LIU Jihong. Analysis on Air Distribution by Computational Fluid Dynamics Simulation in Two Types of Laboratory Animal Barrier Facilities [J]. Laboratory Animal and Comparative Medicine, 2021, 41(3): 252-258.
[15]	CHEN Guoyuan, KANG Kang, LI Xiaoxian, JI Wentao, ZHANG Jinmei, FENG Yanhua, TIAN Qianying, WU Baojin. Application of Experimental Material Inspection in Quality Control of SPF Mice [J]. Laboratory Animal and Comparative Medicine, 2021, 41(1): 61-65.